Prognostic Impact of the Hevylite Assay in Patients With <scp>IgG</scp> or <scp>IgA</scp> Multiple Myeloma Treated Within the <scp>GMMG</scp> ‐ <scp>MM5</scp> Trial

Tim Richardson, Elias Mai, Ekaterina Menis, Axel Benner, Diana Tichy, Kaya Miah, Mathias Hänel, Britta Besemer, Amelie Boquoi, Igor Wolfgang Blau, Christian S. Michel, Hans Walter Lindemann, Snjezana Janjetovic, Peter Brossart, Helga Bernhard, Peter Reimer, Hans Salwender, Dirk Hose, Anja Seckinger, Marc Raab, Hartmut Goldschmidt, Christof Scheid, Unknown

Open source

DOI
10.1111/ejh.70061
Published
2025-11-11
Container
European Journal of Haematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ejh.70061,
  title = {Prognostic Impact of the Hevylite Assay in Patients With
                    <scp>IgG</scp>
                    or
                    <scp>IgA</scp>
                    Multiple Myeloma Treated Within the
                    <scp>GMMG</scp>
                    ‐
                    <scp>MM5</scp>
                    Trial},
  author = {Tim Richardson and Elias Mai and Ekaterina Menis and Axel Benner and Diana Tichy and Kaya Miah and Mathias Hänel and Britta Besemer and Amelie Boquoi and Igor Wolfgang Blau and Christian S. Michel and Hans Walter Lindemann and Snjezana Janjetovic and Peter Brossart and Helga Bernhard and Peter Reimer and Hans Salwender and Dirk Hose and Anja Seckinger and Marc Raab and Hartmut Goldschmidt and Christof Scheid and Unknown},
  year = {2025},
  journal = {European Journal of Haematology},
  doi = {10.1111/ejh.70061},
  url = {https://doi.org/10.1111/ejh.70061}
}

RIS

TY  - JOUR
TI  - Prognostic Impact of the Hevylite Assay in Patients With
                    <scp>IgG</scp>
                    or
                    <scp>IgA</scp>
                    Multiple Myeloma Treated Within the
                    <scp>GMMG</scp>
                    ‐
                    <scp>MM5</scp>
                    Trial
AU  - Tim Richardson
AU  - Elias Mai
AU  - Ekaterina Menis
AU  - Axel Benner
AU  - Diana Tichy
AU  - Kaya Miah
AU  - Mathias Hänel
AU  - Britta Besemer
AU  - Amelie Boquoi
AU  - Igor Wolfgang Blau
AU  - Christian S. Michel
AU  - Hans Walter Lindemann
AU  - Snjezana Janjetovic
AU  - Peter Brossart
AU  - Helga Bernhard
AU  - Peter Reimer
AU  - Hans Salwender
AU  - Dirk Hose
AU  - Anja Seckinger
AU  - Marc Raab
AU  - Hartmut Goldschmidt
AU  - Christof Scheid
AU  - Unknown
PY  - 2025
JO  - European Journal of Haematology
DO  - 10.1111/ejh.70061
UR  - https://doi.org/10.1111/ejh.70061
ER  - 

APA

Richardson, T., Mai, E., Menis, E., Benner, A., Tichy, D., Miah, K., Hänel, M., Besemer, B., Boquoi, A., Blau, I. W., Michel, C. S., Lindemann, H. W., Janjetovic, S., Brossart, P., Bernhard, H., Reimer, P., Salwender, H., Hose, D., Seckinger, A., Raab, M., Goldschmidt, H., Scheid, C., & Unknown (2025). Prognostic Impact of the Hevylite Assay in Patients With <scp>IgG</scp> or <scp>IgA</scp> Multiple Myeloma Treated Within the <scp>GMMG</scp> ‐ <scp>MM5</scp> Trial. European Journal of Haematology. https://doi.org/10.1111/ejh.70061

Source records